Our Research
At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients.
Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.
Our VIEW BOOK
You can find our most recent annual report here: 2023 HMAI Annual Report
Novel medical technology for craniomaxillofacial surgery is cleared by FDA for market
Houston Methodist recently reached a major milestone, receiving U.S. Food and Drug Administration (FDA) 510(k) clearance to market the AnatomicAligner, a novel, comprehensive software program used to improve planning for craniomaxillofacial (CMF) surgeries. Learn more>
Houston Methodist is first to treat COVID-19 with convalescent plasma therapy
Researchers Identify Protein To Aid With Glioblastomas
Center for RNA Therapeutics Awarded Inno Fire Award